T1	Population 51 91	patients with inflammatory bowel disease
T2	Disease 65 91	inflammatory bowel disease
T3	Disease 93 119	Inflammatory bowel disease
T4	Disease 121 124	IBD
T5	DiversityMetric 9194 9205	α-diversity
T6	Population 1860 1872	IBD patients
T7	Disease 523 526	IBD
T8	Population 598 610	IBD patients
T9	Disease 598 601	IBD
T10	Biospecimen 626 631	fecal
T11	Population 663 675	IBD patients
T12	Disease 663 666	IBD
T13	Physiology 483 503	immune dysregulation
T14	ASSOCIATED_WITH 509 522	characterizes
T15	Biospecimen 552 557	fecal
T16	Methodology 704 728	16S rDNA gene sequencing
T17	Methodology 733 747	UHPLC/Q-TOF-MS
T18	Disease 941 944	IBD
T19	DECREASES 976 985	decreased
T20	Microorganism 999 1012	Bacteroidetes
T21	Microorganism 1017 1027	Firmicutes
T22	INCREASES 1029 1038	increased
T23	Microorganism 1072 1086	Proteobacteria
T24	Microorganism 1091 1105	Actinobacteria
T25	INCREASES 1111 1120	increased
T26	Microorganism 1121 1137	Escherichia coli
T27	Microorganism 1142 1163	Klebsiella pneumoniae
T28	Disease 1167 1170	IBD
T29	Methodology 9453 9487	principal component analysis (PCA)
T30	Methodology 9492 9545	non-metric multidimensional scaling (NMDS) statistics
T31	Disease 1269 1272	IBD
T32	Physiology 13262 13285	carbohydrate metabolism
T33	Physiology 13262 13274;13290 13299	carbohydrate transport
T34	Physiology 13316 13342	xenobiotics biodegradation
T35	Physiology 13316 13327;13347 13357	xenobiotics metabolism
T36	Disease 1356 1359	IBD
T37	Metabolite 1394 1421	6,7,4′-trihydroxyisoflavone
T38	Metabolite 1426 1461	thyroxine 4′-o-.beta.-d-glucuronide
T39	Metabolite 1476 1487	normorphine
T40	Metabolite 1523 1537	trichostachine
T41	Metabolite 1492 1504	salvinorin a
T42	Disease 1566 1569	IBD
T43	AFFECTS 1594 1602	affected
T44	Physiology 1622 1652	primary bile acid biosynthesis
T45	Physiology 1654 1686	vitamin digestion and absorption
T46	Physiology 1692 1715	carbohydrate metabolism
T47	Disease 1860 1863	IBD
T48	Biospecimen 1784 1789	fecal
T49	Population 4873 4892	healthy individuals
T50	Population 5152 5161	IBD group
T51	Disease 5152 5155	IBD
T52	Population 5455 5467	IBD patients
T53	Disease 5455 5458	IBD
T54	Microorganism 5477 5487	Firmicutes
T55	Microorganism 5555 5569	Proteobacteria
T56	Microorganism 5628 5641	Bacteroidetes
T57	Microorganism 5659 5675	Escherichia coli
T58	Microorganism 5696 5710	Actinobacteria
T59	Microorganism 5762 5774	Fusobacteria
T60	Microorganism 5827 5838	Tenericutes
T61	Microorganism 5857 5878	Klebsiella pneumoniae
T62	Microorganism 5899 5914	Verrucomicrobia
T63	Microorganism 5933 5951	Bacteroides ovatus
T64	Microorganism 5977 5995	Epsilonbacteraeota
T65	Microorganism 6014 6050	Bifidobacterium longum subsp. longum
T66	Microorganism 6071 6097	PatescibacteriaChloroflexi
T67	Microorganism 6173 6198	Uncultured Bacteroides sp
T68	Methodology 6356 6364	16S rDNA
T69	Methodology 6571 6577	UCLUST
T70	Methodology 6581 6586	QIIME
T71	Population 6820 6832	IBD patients
T72	Disease 6820 6823	IBD
T73	DECREASES 6837 6844	reduced
T74	Microorganism 6855 6865	Firmicutes
T75	Microorganism 6867 6878	Bacteroides
T76	Microorganism 6880 6892	Fusobacteria
T77	Microorganism 6898 6909	Tenericutes
T78	INCREASES 6914 6923	increased
T79	Microorganism 6937 6951	Proteobacteria
T80	Microorganism 6956 6970	Actinobacteria
T81	Disease 7053 7056	IBD
T82	Population 7053 7063	IBD groups
T83	Microorganism 7279 7295	Escherichia coli
T84	Microorganism 7297 7318	Klebsiella pneumoniae
T85	Microorganism 7320 7356	Bifidobacterium longum subsp. Longum
T87	Microorganism 7358 7381	Bacteroides ovatus V975
T88	Microorganism 7415 7440	uncultured Bacteroides sp
T89	Disease 7682 7685	IBD
T90	Methodology 7655 7678	phylum-level clustering
T91	INCREASES 7712 7721	increased
T92	Microorganism 7735 7749	Proteobacteria
T93	Microorganism 7751 7765	Actinobacteria
T94	Microorganism 7771 7786	Verrucomicrobia
T95	Disease 7984 7987	IBD
T96	DECREASES 8000 8007	reduced
T97	Microorganism 8008 8019	Bacteroides
T98	Microorganism 8021 8030	Dialister
T99	Microorganism 8032 8047	Subdoligradulum
T100	Microorganism 8053 8067	Ruminococcus 2
T101	INCREASES 8073 8082	increased
T102	Microorganism 8096 8116	Escherichia-Shigella
T103	Microorganism 8121 8136	Bifidobacterium
T104	DiversityMetric 8138 8144;8154 8163	Alpha- diversity
T105	DiversityMetric 8149 8163	beta-diversity
T106	Disease 8201 8204	IBD
T107	Population 8201 8213	IBD patients
T108	DiversityMetric 8220 8231	β diversity
T109	DiversityMetric 8214 8215;8222 8231	α diversity
T110	DiversityMetric 8279 8290	α diversity
T111	DiversityMetric 8373 8384	α diversity
T112	DiversityMetric 8655 8666	β diversity
T113	DiversityMetric 8766 8777	α-diversity
T114	Disease 9006 9009	IBD
T115	Disease 9603 9606	IBD
T116	DiversityMetric 9635 9646	α-diversity
T117	DiversityMetric 10107 10118	β-diversity
T118	DiversityMetric 10226 10237	β diversity
T119	DiversityMetric 10344 10355	β-diversity
T120	Population 10363 10372	IBD group
T121	Disease 10363 10366	IBD
T122	Disease 10449 10452	IBD
T123	Disease 10510 10513	IBD
T124	Disease 10581 10584	IBD
T125	Population 10581 10590	IBD group
T126	Population 10633 10642	IBD group
T127	Disease 10633 10636	IBD
T128	Disease 10699 10702	IBD
T129	Population 10699 10708	IBD group
T130	Disease 10939 10942	IBD
T131	Biospecimen 10943 10948	stool
T132	Methodology 10551 10565	LEFSe analysis
T133	Methodology 10988 10993	LEfSe
T134	Disease 11228 11231	IBD
T135	Microorganism 11300 11315	Enterococcaceae
T136	Microorganism 11320 11336	Lactobacillaceae
T137	Microorganism 11352 11364	Enterococcus
T138	Microorganism 11366 11379	Lactobacillus
T139	Microorganism 11385 11396	Eggerthella
T140	Disease 11467 11470	IBD
T141	Population 11467 11476	IBD group
T142	ASSOCIATED_WITH 11437 11459	play an important role
T143	Methodology 11542 11569	STAMP differential analysis
T144	Disease 11645 11648	IBD
T145	Population 11645 11654	IBD group
T146	Population 11664 11677	healthy group
T147	Microorganism 11738 11747	Dialister
T148	Microorganism 11749 11758	Alistipes
T149	Microorganism 11760 11775	Subdoligranulum
T150	Microorganism 11777 11800	Ruminococcaceae UCG-002
T151	Microorganism 11777 11792;11802 11809	Ruminococcaceae UCG-005
T152	Microorganism 11777 11792;11811 11818	Ruminococcaceae UCG-010
T153	Microorganism 11824 11837	Coprococcus 2
T154	DECREASES 11708 11715	reduced
T155	INCREASES 11843 11852	increased
T156	Microorganism 11866 11878	Anaerostipes
T157	Microorganism 11881 11892	Eubacterium
T158	Microorganism 11894 11906	hallii group
T159	Microorganism 11912 11923	Eggerthella
T160	Methodology 11997 12016	KEGG STAMP analysis
T161	Methodology 12086 12106	COG heatmap analysis
T162	Methodology 12176 12194	COG STAMP analysis
T163	Disease 12605 12608	IBD
T164	Methodology 12641 12648	PICRUSt
T165	Methodology 12782 12796	16S sequencing
T166	Methodology 12915 12945	COG homologous protein cluster
T167	Methodology 13021 13025	KEGG
T168	Methodology 13103 13107	KEGG
T169	Methodology 13112 13115	COG
T170	Disease 13186 13189	IBD
T171	Population 13186 13195	IBD group
T172	Methodology 13200 13214	STAMP analysis
T173	Disease 13683 13686	IBD
T174	Population 13683 13692	IBD group
T175	Methodology 13704 13722	LEfSe LDA analysis
T176	Methodology 13732 13762	COG homologous protein cluster
T177	Disease 13904 13907	IBD
T178	Population 13904 13913	IBD group
T179	DECREASES 13925 13932	reduced
T180	Physiology 13933 13968	translation of ribosomal structures
T181	Physiology 13948 13957;13973 13983	ribosomal biogenesis
T182	Physiology 13989 14008	chromatin structure
T183	Physiology 13989 13998;14013 14021	chromatin dynamics
T184	INCREASES 13814 13822	elevated
T185	Physiology 13823 13845	carbohydrate transport
T186	Physiology 13823 13835;13850 13860	carbohydrate metabolism
T187	Physiology 13865 13896	RNA processing and modification
T188	Disease 14217 14220	IBD
T189	Disease 14547 14550	IBD
T190	Physiology 14575 14607	Vitamin digestion and absorption
T191	Physiology 14609 14639	primary bile acid biosynthesis
T192	Physiology 14641 14673	protein digestion and absorption
T193	Gene 14675 14691	ABC transporters
T194	Disease 14693 14713	basal cell carcinoma
T195	Physiology 14715 14737	glutathione metabolism
T196	Disease 14739 14750	ferroptosis
T197	Disease 26648 26651	IBD
T198	Disease 26748 26751	IBD
T199	Microorganism 26494 26505	Eggerthella
T200	Methodology 25934 25949	Cytoscape 3.5.1
T201	Microorganism 26535 26547	Enterococcus
T202	Microorganism 25526 25539	Lactobacillus
T203	POS_ASSOCIATED_WITH 25544 25576	positive significant correlation
T204	Metabolite 25606 25614	L-valine
T205	Metabolite 25628 25648	N-nitrosopyrrolidine
T206	Metabolite 25650 25659	calycosin
T207	Metabolite 25661 25669	apigenin
T208	Metabolite 25671 25692	flavin mononucleotide
T209	Metabolite 25694 25701	his-met
T210	Metabolite 25703 25711	luteolin
T211	Metabolite 25717 25735	1,2,3-benzenetriol
T212	NEG_ASSOCIATED_WITH 25752 25784	negative significant correlation
T213	Metabolite 25815 25836	25-hydroxycholesterol
T214	Metabolite 25838 25850	androsterone
T216	Metabolite 25852 25867	ginsenoside rh2
T217	Metabolite 25869 25880	pristimerin
T218	Metabolite 25886 25897	cholesterol
T219	Microorganism 25191 25202	Eggerthella
T220	Microorganism 24615 24627	Enterococcus
T221	Metabolite 25493 25512	piperonyl sulfoxide
T222	Metabolite 25479 25491	Asiatic acid
T223	Metabolite 25469 25477	neomycin
T224	Metabolite 25455 25467	hypoxanthine
T225	Metabolite 25437 25453	lithocholic acid
T226	Metabolite 25423 25435	salvinorin a
T227	Metabolite 25412 25421	hecogenin
T228	NEG_ASSOCIATED_WITH 25360 25381	negatively correlated
T229	Metabolite 25335 25343	luteolin
T230	Metabolite 25322 25329	his-met
T231	Metabolite 25299 25320	flavin mononucleotide
T232	Metabolite 25289 25297	apigenin
T233	Metabolite 25278 25287	calycosin
T234	Metabolite 25267 25276	delsoline
T235	Metabolite 25255 25265	corydaline
T236	POS_ASSOCIATED_WITH 25203 25224	positively correlated
T237	POS_ASSOCIATED_WITH 24632 24664	positive significant correlation
T238	Metabolite 24695 24706	cholic acid
T239	Metabolite 24708 24717	calycosin
T240	Metabolite 24723 24743	N-nitrosopyrrolidine
T241	Metabolite 24761 24782	flavin mononucleotide
T242	Metabolite 24784 24792	apigenin
T243	Metabolite 24794 24802	L-valine
T246	Metabolite 24808 24864	3alpha,7beta,12alpha-trihydroxy-5beta-cholan-24-oic acid
T247	NEG_ASSOCIATED_WITH 24881 24915	negatively significant correlation
T248	Metabolite 24946 24961	ginsenoside rh2
T249	Metabolite 24963 24975	androsterone
T250	Metabolite 24977 25000	indole-3-carboxaldehyde
T251	Metabolite 25002 25014	salvinorin a
T252	Metabolite 25016 25035	isodeoxycholic acid
T253	Metabolite 25041 25057	lithocholic acid
T254	Metabolite 25075 25083	glycerol
T255	Metabolite 25085 25091	uracil
T256	Metabolite 25093 25103	oxypurinol
T257	Metabolite 25105 25126	25-hydroxycholesterol
T258	Metabolite 25128 25148	glycolithocholic aid
T259	Metabolite 25150 25158	xanthine
T260	Metabolite 25164 25178	hypoxyxanthine
T261	Methodology 24045 24062	Spearman analysis
T262	Methodology 23648 23677	Spearman correlation analysis
T263	Population 23836 23845	IBD group
T264	Disease 23836 23839	IBD
T265	Microorganism 23931 23942	Eggerthella
T266	Microorganism 23944 23956	Enterococcus
T267	Microorganism 23958 23971	Lactobacillus
T268	Methodology 24086 24125	correlation coefficient matrix heat map
T269	Methodology 24130 24162	hierarchical clustering heat map
T270	Methodology 22622 22670	Spearman correlation coefficient matrix heat map
T271	Methodology 22722 22784	Spearman correlation analysis hierarchical clustering heat map
T272	Disease 22522 22525	IBD
T273	Disease 22423 22426	IBD
T274	Population 22423 22435	IBD patients
T275	Population 22448 22467	healthy individuals
T276	Methodology 22008 22034	Pathway hierarchy analysis
T277	Disease 22066 22069	IBD
T278	Population 22066 22078	IBD patients
T279	Physiology 22088 22103	cancer function
T280	Physiology 22105 22126	cell growth and death
T281	Physiology 22146 22162	lipid metabolism
T282	Physiology 22164 22182	membrane transport
T283	Physiology 22188 22211	metabolism of cofactors
T284	Physiology 22188 22201;22213 22221	metabolism of vitamins
T285	Physiology 22188 22201;22233 22244	metabolism of amino acids
T286	Methodology 21903 21907	KEGG
T287	Gene 21836 21849	ABC transport
T288	Physiology 21543 21575	vitamin digestion and absorption
T289	Physiology 21577 21607	primary bile acid biosynthesis
T290	Physiology 21609 21626	protein digestion
T291	Physiology 21609 21616;21632 21642	protein absorption
T292	Physiology 21644 21663	thiamine metabolism
T293	Physiology 21665 21687	glutathione metabolism
T294	Gene 21689 21705	ABC transporters
T295	Physiology 21707 21742	central carbon metabolism in cancer
T296	Disease 21736 21742	cancer
T297	Disease 21748 21759	ferroptosis
T298	Methodology 21268 21300	KEGG pathway enrichment analysis
T299	Methodology 21329 21348	Fisher’s Exact Test
T300	Disease 21435 21438	IBD
T301	Physiology 21403 21431	signal transduction pathways
T302	Physiology 21389 21398;21410 21431	metabolic transduction pathways
T303	Population 19861 19870	IBD group
T304	Disease 19861 19864	IBD
T305	Methodology 19507 19563	KEGG pathway differential metabolite clustering heat map
T306	Gene 19567 19580	ABC transport
T307	Methodology 19584 19621	KEGG metabolic pathway enrichment map
T308	Disease 19187 19190	IBD
T309	Methodology 19127 19139	AUC analysis
T310	Disease 18787 18790	IBD
T311	Metabolite 18827 18854	6,7,4′-trihydroxyisoflavone
T312	Metabolite 18869 18904	thyroxine 4'-o-.beta.-d-glucuronide
T313	Metabolite 18919 18933	trichostachine
T314	Metabolite 18948 18959	normorphine
T315	Metabolite 18978 18990	salvinorin a
T316	Disease 15693 15696	IBD
T317	Metabolite 16384 16411	6,7,4'-trihydroxyisoflavone
T318	Physiology 13374 13398	transport of amino acids
T319	Disease 16593 16596	IBD
T320	Population 16593 16602	IBD group
T321	Methodology 16661 16749	ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry
T322	Methodology 16751 16765	UHPLC-Q-TOF MS
T323	Disease 17098 17101	IBD
T324	Metabolite 17901 17910	Calycosin
T325	Metabolite 17912 17919	His-Met
T326	Metabolite 17921 17939	1,2,3-benzenetriol
T327	Metabolite 17941 17959	G(8-o-4)fa sulfate
T328	Metabolite 17965 17990	Alpha.-apooxytetracycline
T329	Metabolite 18030 18046	Lithocholic acid
T330	Metabolite 18048 18057	Clausarin
T331	Metabolite 18059 18074	Ginsenoside rh2
T332	Metabolite 18076 18095	Isodeoxycholic acid
T333	Metabolite 18101 18120	Propylpyrazoletriol
T334	Physiology 13359 13369;13384 13398	metabolism of amino acids
T335	Metabolite 16422 16557	[(2r,3 s,4 s,5r,6r)-3,4,5-trihydroxy-6-[2-(3-hydroxy-5-oxooxolan-3-yl)propoxy]oxan-2-yl]methyl (e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
T336	Metabolite 26510 26529	piperonyl sulfoxide
T337	Metabolite 26552 26572	N-nitrosopyrrolidine
T338	Metabolite 18233 18257	P-methoxymethamphetamine
T339	Metabolite 18259 18267	Apigenin
T340	Metabolite 18269 18287	O-methylarmepavine
T341	Metabolite 18289 18325	2,5-dimethoxy-4-methylphenethylamine
T342	Metabolite 18331 18339	Luteolin
T344	Metabolite 18348 18540	1(2 h)-pyrimidineacetamide, n-[(1 s,3 s,4 s)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-4-hydroxy-.alpha.-(1-methylethyl)-2-oxo-, (.alpha.s)-
T346	Metabolite 18542 18557	Isocaproic acid
T347	Metabolite 18559 18574	Garcinolic acid
T348	Metabolite 18576 18604	Anhydroecgonine methyl ester
T349	Metabolite 18610 18622	Salvinorin a
T350	Metabolite 14844 14871	6,7,4′-trihydroxyisoflavone
T351	Metabolite 14879 14914	Thyroxine 4′-o-.beta.-d-glucuronide
T352	Metabolite 14922 14936	Trichostachine
T353	Metabolite 14944 15079	[(2r,3 s,4 s,5r,6r)-3,4,5-trihydroxy-6-[2-(3-hydroxy-5-oxooxolan-3-yl)propoxy]oxan-2-yl]methyl (e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
T354	Metabolite 15087 15098	Normorphine
T355	Metabolite 15106 15118	Salvinorin a
T356	Metabolite 15126 15135	Esculetin
T357	Metabolite 15143 15156	Mitraphylline
T358	Metabolite 15164 15187	Indole-3-carboxaldehyde
T359	Metabolite 15195 15210	Ginsenoside rh2
T360	Metabolite 15218 15239	Arachidonoylserotonin
T361	Metabolite 15247 15297	11-hydroxy-5z,8z,12e,14z,17z-eicosapentaenoic acid
T362	Metabolite 15305 15328	10-deacetylbaccatin iii
T363	Metabolite 15336 15349	9-cis-retinol
T364	Metabolite 15357 15424	(5-benzoyloxy-3-chloro-4,6-dihydroxycyclohexen-1-yl)methyl benzoate
T365	Metabolite 15432 15526	[(4e)-7-acetyloxy-6-hydroxy-2-methyl-10-oxo-2,3,6,7,8,9-hexahydrooxecin-3-yl] (e)-but-2-enoate
T366	Metabolite 15534 15550	Dihydroberberine
T367	Metabolite 15558 15579	N-nitrosopyrroolidine
T368	Metabolite 15587 15602	Prothioconazole
T369	Metabolite 15610 15627	Patchouli alcohol
T4611	Disease 4795 4798	IBD
T4711	Population 4803 4822	healthy individuals
T4811	Disease 4865 4868	IBD
E1	ASSOCIATED_WITH:T14 Theme:T13 Theme2:T7
E2	DECREASES:T19 Theme:T20 Agent:T28
E3	INCREASES:T22 Theme:T23 Agent:T28
E4	INCREASES:T25 Theme:T26 Agent:T28
E5	INCREASES:T25 Theme:T27 Agent:T28
E6	DECREASES:T19 Theme:T21 Agent:T28
E7	INCREASES:T22 Theme:T24 Agent:T28
E10	AFFECTS:T43 Agent:T42 Theme:T44
E11	AFFECTS:T43 Agent:T42 Theme:T46
E12	AFFECTS:T43 Agent:T42 Theme:T45
E15	DECREASES:T73 Agent:T72 Theme:T74
E16	INCREASES:T78 Agent:T72 Theme:T79
E17	DECREASES:T73 Agent:T72 Theme:T75
E18	DECREASES:T73 Agent:T72 Theme:T76
E19	DECREASES:T73 Agent:T72 Theme:T77
E20	INCREASES:T78 Agent:T72 Theme:T80
E21	INCREASES:T91 Agent:T89 Theme:T92
E22	INCREASES:T91 Agent:T89 Theme:T93
E23	INCREASES:T91 Agent:T89 Theme:T94
E24	DECREASES:T96 Agent:T95 Theme:T97
E25	INCREASES:T101 Agent:T95 Theme:T102
E26	DECREASES:T96 Agent:T95 Theme:T98
E27	DECREASES:T96 Agent:T95 Theme:T99
E28	DECREASES:T96 Agent:T95 Theme:T100
E29	INCREASES:T101 Agent:T95 Theme:T103
E30	ASSOCIATED_WITH:T142 Theme:T139 Theme2:T140
E31	ASSOCIATED_WITH:T142 Theme:T138 Theme2:T140
E32	ASSOCIATED_WITH:T142 Theme:T137 Theme2:T140
E33	ASSOCIATED_WITH:T142 Theme:T136 Theme2:T140
E34	ASSOCIATED_WITH:T142 Theme:T135 Theme2:T140
E35	DECREASES:T154 Agent:T144 Theme:T147
E36	INCREASES:T155 Agent:T144 Theme:T156
E37	INCREASES:T155 Agent:T144 Theme:T157
E38	INCREASES:T155 Agent:T144 Theme:T159
E39	DECREASES:T154 Agent:T144 Theme:T148
E40	DECREASES:T154 Agent:T144 Theme:T149
E41	DECREASES:T154 Agent:T144 Theme:T153
E42	DECREASES:T154 Agent:T144 Theme:T152
E43	DECREASES:T154 Agent:T144 Theme:T151
E44	DECREASES:T154 Agent:T144 Theme:T150
E45	DECREASES:T179 Agent:T177 Theme:T183
E46	INCREASES:T184 Agent:T177 Theme:T186
E47	INCREASES:T184 Agent:T177 Theme:T185
E48	INCREASES:T184 Agent:T177 Theme:T187
E49	DECREASES:T179 Agent:T177 Theme:T182
E50	DECREASES:T179 Agent:T177 Theme:T181
E51	DECREASES:T179 Agent:T177 Theme:T180
E52	POS_ASSOCIATED_WITH:T203 Agent:T202 Theme:T204
E53	NEG_ASSOCIATED_WITH:T212 Agent:T202 Theme:T218
E54	POS_ASSOCIATED_WITH:T203 Agent:T202 Theme:T205
E55	POS_ASSOCIATED_WITH:T203 Agent:T202 Theme:T206
E56	POS_ASSOCIATED_WITH:T203 Agent:T202 Theme:T207
E57	POS_ASSOCIATED_WITH:T203 Agent:T202 Theme:T208
E58	POS_ASSOCIATED_WITH:T203 Agent:T202 Theme:T209
E59	POS_ASSOCIATED_WITH:T203 Agent:T202 Theme:T210
E60	POS_ASSOCIATED_WITH:T203 Agent:T202 Theme:T211
E61	NEG_ASSOCIATED_WITH:T212 Agent:T202 Theme:T217
E62	NEG_ASSOCIATED_WITH:T212 Agent:T202 Theme:T216
E64	NEG_ASSOCIATED_WITH:T212 Agent:T202 Theme:T214
E65	NEG_ASSOCIATED_WITH:T212 Agent:T202 Theme:T213
E66	NEG_ASSOCIATED_WITH:T228 Agent:T219 Theme:T227
E67	POS_ASSOCIATED_WITH:T236 Agent:T219 Theme:T235
E68	POS_ASSOCIATED_WITH:T237 Agent:T220 Theme:T238
E69	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T248
E70	POS_ASSOCIATED_WITH:T237 Agent:T220 Theme:T239
E71	POS_ASSOCIATED_WITH:T237 Agent:T220 Theme:T240
E72	POS_ASSOCIATED_WITH:T237 Agent:T220 Theme:T241
E73	POS_ASSOCIATED_WITH:T237 Agent:T220 Theme:T242
E74	POS_ASSOCIATED_WITH:T237 Agent:T220 Theme:T243
E77	POS_ASSOCIATED_WITH:T237 Agent:T220 Theme:T246
E78	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T249
E79	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T250
E80	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T251
E81	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T252
E82	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T253
E83	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T254
E84	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T255
E85	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T256
E86	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T257
E87	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T258
E88	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T259
E89	NEG_ASSOCIATED_WITH:T247 Agent:T220 Theme:T260
E90	NEG_ASSOCIATED_WITH:T228 Agent:T219 Theme:T226
E91	NEG_ASSOCIATED_WITH:T228 Agent:T219 Theme:T221
E92	NEG_ASSOCIATED_WITH:T228 Agent:T219 Theme:T222
E93	NEG_ASSOCIATED_WITH:T228 Agent:T219 Theme:T223
E94	NEG_ASSOCIATED_WITH:T228 Agent:T219 Theme:T224
E95	NEG_ASSOCIATED_WITH:T228 Agent:T219 Theme:T225
E96	POS_ASSOCIATED_WITH:T236 Agent:T219 Theme:T234
E97	POS_ASSOCIATED_WITH:T236 Agent:T219 Theme:T233
E98	POS_ASSOCIATED_WITH:T236 Agent:T219 Theme:T232
E99	POS_ASSOCIATED_WITH:T236 Agent:T219 Theme:T231
E100	POS_ASSOCIATED_WITH:T236 Agent:T219 Theme:T230
E101	POS_ASSOCIATED_WITH:T236 Agent:T219 Theme:T229